All In MedTech

Device Trial Radar · NCT06828770

Minima Stent System Post- Approval Study (PAS)

Post-Approval Study of the Renata Minima Stent in the Treatment of Vascular Stenoses in Neonates, Infants, and Small Children

Last checked: Nov 20, 2026Latest source record: Oct 23, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

100

Planned (sponsor's estimate)

Start

May 21, 2025

Primary completion

May 2027

Study completion Dec 2031

Sponsor

Lead sponsor
Renata MedicalNot on our public-company list
Sponsor type
Industry
First posted
Feb 14, 2025

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This Post-Approval Study is a single arm, prospective, multi-center, open-label study of patients treated with the Renata Minima Stent System in the United States. The objective of the study is to continue the assessment of device performance and capture outcome data on use of the device in real-world use.

Conditions

  • Pulmonary Artery Stenosis
  • Aortic Coarctation

Interventions

  • Minima Stent SystemDevice

    Minima Stent System is indicated for use in the treatment of native or acquired pulmonary artery stenoses or coarctation of the aorta in neonates, infants, and children at least 1.5kg in weight.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rate of Acute Device SuccessTime frame: End of Procedure (Following Implantation of the Stent)

1 more outcomes with a free account

Locations

15 sites in 1 country. Site status is shown where the registry gives one.

  • Children's Hospital Los Angeles

    Los Angeles, California · Recruiting

14 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.